Viewing StudyNCT00020670



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00020670
Status: TERMINATED
Last Update Posted: 2017-06-20
First Post: 2001-07-11

Brief Title: Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 00-053
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Nicholas Haining MD
Responsible Party Title: Haining Nicholas MD
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Dana-Farber Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH